维普期刊资源整合服务平台（V6.5）

78篇 您的检索式：作者名="HOWELL SB"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Cellular pharmacology of cisplatin:perspectives on mechanisms of acquired resistance显示文摘	Andrews PA Howell SB	1990	Cancer Cells1990，2，：	1
2	Copper transporters and the cellular pharmacology of the plati- num-containing cancer drugs 显示文摘	Howell SB Safaei R Larson CA	2010	Mol Pharmacol2010，77，6：	1
3	Copper transporters andthe cellular pharmacology of the platinum-containing cancerdrugs 显示文摘	Howell SB Safaei R Larson CA	2010	Mol Pharmacol2010，77，6：	1
4	Comparison of the synergis tic potentiation of etoposide, doxorubicin, and vinblastive cytotoxicity by dipyridamLoe 显示文摘	Howell SB Hom D Sanga R	1989	Cancer Res1989，49，：	1
5	Cellular pharmacology ofcisplatin: persprives on mechanisms of acquired resistance显示文摘	Androws PA Howell SB	1990	Cancer Cells1990，2，：	1
6	Multivesicular liposomes containing cytarabine for slow-releasesc administration显示文摘	KIM S HOWELL SB	1987	Cancer Treat Rep1987，71，5：	1
7	CD44-targeted microparticles for de-livery of cisplatin to peritoneal metastases显示文摘	Li SD Howell SB		0，，01：	1
8	The role of DNA mismatch repair in drug resistance显示文摘	Fink D Aebi S Howell SB	1998	Clin Cancer Res1998，4，1：	1
9	Comparison of the synergistic potentiation of etoposide,doxorubicin,and vinblastive cytotoxicity by dipyridamloe 显示文摘	Howell SB Hom D Sanga R	1989	Cancer Res1989，49，12：	1
10	Clinical applications of a novel sustained release iniectable drug delivery system: Depofoam teehnology显示文摘	Howell SB	2001	Cancer J2001，7，3：	1
11	Acquisition of resistance to cisplatin is accompanied by changes in the cellular pharmacology of copper显示文摘	Katano K Kondo A Safaei R Holzer A Samimi G Mishima M Kuo YM Rochdi M Howell SB	2002	Cancer Res2002，62，22：	1
12	Contribution of the major copper influx transporter CTR1 to the cellular accumulation of cisplatin, carboplatin, and oxaliplatin显示文摘	Holzer AK Manorek GH Howell SB	2006	Mol Pharmacol2006，70，4：	1
13	Copper transporters and the cellular pharmacology of the platinum-containing canc- er drugs显示文摘	Howell SB Safaei R Larson CA	2010	Mol Pharmacol2010，77，6：	1
14	Claudin-4 controls the receptor tyrosine kinase EphA2 pro-oncogenic switch through β-catenin 显示文摘	Shang X Lin X Howell SB	2014	Cell Commun Signal2014，12，：	1
15	The internalization and degradation ofhuman copper transporter 1 following cisplatin exposure 显示文摘	Holzer AK Howell SB	2006	CancerRes2006，66，10：	1
16	CD44-targeted micropartieles for delivery of cisplatin to peritoneal metastases 显示文摘	Li SD Howell SB	2010	Mol Pharm2010，7，1：	1
17	Clinical applications of a novel sustained-releas injectable drug deliv-ery system: DepoFoam technology显示文摘	Howell SB	2001	Cancer J2001，7，3：	1
18	Copper transporters and the cellular pharmacology of the platinum-containing cancer drugs显示文摘	Howell SB Safaei R Larson CA Sailor MJ	2010	Mol Pharmacol2010，77，6：	1
19	Intraperitoneal cisplatin with systemic thiosulfate protection显示文摘	Howell SB Pfeifle CL Wung WE	1982	Ann Intem Med1982，97，：	1
20	Molecular modeling of the intrastrand guanine-guanine DNA adducts produced by cisplatin and oxaliplatin显示文摘	Scheeff ED Briggs JM Howell SB	1999	Mol Pharmacol1999，56，：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示